Shackles are off!

AGM is done. Uncertainty on resolutions gone.

Marketing - of course you spend more with little return as you build awareness. They are doing the right thing doing this pre FDA approval and US market launch.

Rest of world - they are a team of 37 people. They are right to focus their energy on the most lucrative market, the US. This is where I want them focusing. The rest will come and follow in good time.

Capital - they have the capital they need now.

Share price - momentum has kicked in. Eyes are on the prize next year. Return to last years SP happening now. Even higher SP as we get close to FDA approval. Honestly, who here doesn't think when FDA approval is announced the SP won't soar by 30-50% the next day? (SP dependent).

Future - once commercialisation kicks in the everyone will be looking at the market for AVH. No more penny stock startup hopes, potential for this and that, that stuff is done and in the rear view mirror from next year. Revenue will be the talk. $5B+ alone just USA. Once momentum gets going there, rest of world including China will add to that, possibly even more.

Product - simply its a better way of treating burns and wounds. Once awareness kicks in this will sell itself. Once something is the new standard you'd have to be negligent for not using/offering it. Not to mention the economics - its actually better financially to use it as less care costs are required.